Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biofabrication & Biomanufacturing Europe 2019

Jose Manuel Baena's Biography



Jose Manuel Baena, CEO, REGEMAT 3D

Scientist in Regenerative Medicine and Advanced Therapies. Enthusiastic and motivated healthcare entrepreneur and CEO, bringing new technologies from lab to bed to improve people's quality of life. Working in more than 15 countries. Founder and CEO of BRECA Health Care and REGEMAT 3D. Pioneering the revolution of 3D printing and bioprinting in healthcare. Technological entrepreneurship, business development and internationalization. Professional of biomedical engineering and biomechanics, 3D bioprinting, medical devices development, CAD, CFD, FE. Creating models to simulate complex environments and make decisions. Using technology to improve peoples quality of life. Specialties: Healthcare, Medical devices, Science, Research, Strategic marketing, Business development, Sales & marketing team management, Key opinion leader management, Product launch, Marketing communication, Life sciences start ups and R&D performing SME, Bioprinting and 3D printing expert, Scientific communication, Sales analysis and forecasting, International marketing management, Scientific project management.

Jose Manuel Baena Image

An Improved Bio-fabrication Process to Enhance Cell Survival of Cartilage Regeneration and Functionality of the Osteoarthritic Knee when Enriched with Bone Marrow Mesenchymal Stem Cells (MSC)

Friday, 21 June 2019 at 15:30

Add to Calendar ▼2019-06-21 15:30:002019-06-21 16:30:00Europe/LondonAn Improved Bio-fabrication Process to Enhance Cell Survival of Cartilage Regeneration and Functionality of the Osteoarthritic Knee when Enriched with Bone Marrow Mesenchymal Stem Cells (MSC)Biofabrication and Biomanufacturing Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Tissue regeneration (TR) is currently one of the most challenging biotechnology unsolved problems. Tissue engineering (TE) is a multidisciplinary science that aims at solving the problems of TR. TE could solve pathologies and improve the quality of life of billions of people around the world suffering from tissue damages. New advances in stem cell (SC) research for the regeneration of tissue injuries have opened a new promising research field. However, research carried out nowadays with twodimensional (2D) cell cultures do not provide the expected results, as 2D cultures do not mimic the 3D structure of a living tissue. Some of the commonly used polymers for cartilage regeneration are Poly-lactic acid (PLA) and its derivate as Poly-L-lactic acid (PLLA), Poly (glycolic acids) (PGAs) and derivate as Poly (lactic-co-glycolic acids) (PLGAs) and Poly caprolactone (PCL). All these materials can be printed using fused deposition modelling (FDM), a process in which a heated nozzle melt a thermoplastic filament and deposit it in a surface, drawing the outline and the internal filling of every layer. All these procedures use melting temperatures that decrease viability and cell survival. Research groups around the world are focusing their efforts in finding low temperature printing thermoplastics or restricted geometries that avoid the contact of the thermoplastic and cells at a higher temperature than the physiologically viable. This has mainly 2 problems; new biomaterials need a long procedure of clearance before they can be used in clinical used, and restrictions in geometries will limit the clinical application of 3D printing in TE.


Add to Calendar ▼2019-06-20 00:00:002019-06-21 00:00:00Europe/LondonBiofabrication and Biomanufacturing Europe 2019Biofabrication and Biomanufacturing Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com